Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation

被引:110
|
作者
Grattagliano, Ignazio [1 ]
de Bari, Ornella [1 ,2 ]
Bernardo, Telma C. [3 ]
Oliveira, Paulo J. [3 ]
Wang, David Q. -H. [2 ]
Portincasa, Piero [1 ]
机构
[1] Univ Bari, Dept Interdisciplinary Med, Clin Med A Murri, Sch Med, Bari, Italy
[2] St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, St Louis, MO USA
[3] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal
基金
美国国家卫生研究院;
关键词
Breath tests; Nonalcoholic fatty liver disease; Mitochondria; Oxidative stress; Fatty acid beta-oxidation; PERMEABILITY TRANSITION; HEPATIC STEATOSIS; OXIDATIVE STRESS; ACID OXIDATION; MACROVESICULAR STEATOSIS; METABOLIC SYNDROME; BETA-OXIDATION; COMPLEX-I; RAT; DYSFUNCTION;
D O I
10.1016/j.clinbiochem.2012.03.024
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Mitochondria play a major role in cell energy-generating processes and integrate several signalling pathways to control cellular life and death. Design and methods: Several liver diseases are characterized by mitochondrial alterations which are directly or indirectly dependent on the activation of intracellular stress cascades or receptor-mediated pathways. This article examines the role of mitochondrial dysfunction in critical initiating or propagating events in fatty liver infiltration and nonalcoholic fatty liver disease (NAFLD). Genetic variants and the role of drug-induced toxicity have been considered. Results: Key alterations of mitochondrial physiology associated with hepatocyte fatty changes are described. The value of novel non-invasive diagnostic methods to detect mitochondria( metabolic alterations is also discussed. Conclusions: Mitochondrial metabolic remodeling is a predominant factor in the appearance and perpetuation of hepatocyte fat accumulation. Non-invasive techniques to identify mitochondrial dysfunction and proper mitochondria protection are two necessary clinical steps for an efficient management of NAFLD. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:610 / 618
页数:9
相关论文
共 50 条
  • [21] The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Cha J.-Y.
    Kim D.-H.
    Chun K.-H.
    Laboratory Animal Research, 2018, 34 (4) : 133 - 139
  • [22] Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
    Karkucinska-Wieckowska, Agnieszka
    Simoes, Ines C. M.
    Kalinowski, Piotr
    Lebiedzinska-Arciszewska, Magdalena
    Zieniewicz, Krzysztof
    Milkiewicz, Piotr
    Gorska-Ponikowska, Magdalena
    Pinton, Paolo
    Malik, Afshan N.
    Krawczyk, Marcin
    Oliveira, Paulo J.
    Wieckowski, Mariusz R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (03)
  • [23] Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
    Di Ciaula, Agostino
    Passarella, Salvatore
    Shanmugam, Harshitha
    Noviello, Marica
    Bonfrate, Leonilde
    Wang, David Q. -H.
    Portincasa, Piero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [24] The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Chow, Monica D.
    Lee, Yi-Horng
    Guo, Grace L.
    MOLECULAR ASPECTS OF MEDICINE, 2017, 56 : 34 - 44
  • [25] Role of extracellular vesicles in nonalcoholic fatty liver disease
    Jiang, Wei
    Xu, Youhui
    Chen, Jou-Chen
    Lee, Yi-Hung
    Hu, Yushin
    Liu, Chang-Hai
    Chen, Enqiang
    Tang, Hong
    Zhang, Hua
    Wu, Dongbo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [26] Emerging role of carboxylesterases in nonalcoholic fatty liver disease
    Liu, Jie
    Yao, Bingyi
    Gao, Liangcai
    Zhang, Yuanjin
    Huang, Shengbo
    Wang, Xin
    BIOCHEMICAL PHARMACOLOGY, 2022, 205
  • [27] Role of TWEAK in the Pathogenesis of Nonalcoholic Fatty Liver Disease
    Polat, Zulfikar
    Uygun, Ahmet
    Ozel, A. Melih
    Basaranoglu, Metin
    Aslan, Fatih
    Gulsen, Mustafa
    Bagci, Sait
    GASTROENTEROLOGY, 2013, 144 (05) : S1011 - S1012
  • [28] Role of cenicriviroc in the management of nonalcoholic fatty liver disease
    Georgios Neokosmidis
    Konstantinos Tziomalos
    World Journal of Gastroenterology, 2018, (48) : 5415 - 5417
  • [29] The role of exosomal miRNA in nonalcoholic fatty liver disease
    Mahmoudi, Ali
    Butler, Alexandra E.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (04) : 2078 - 2094
  • [30] The role of the gut microbiota in nonalcoholic fatty liver disease
    Ahmed Abu-Shanab
    Eamonn M. M. Quigley
    Nature Reviews Gastroenterology & Hepatology, 2010, 7 : 691 - 701